- Home
- NOTE vs MGX Comparison
NOTE vs MGX Comparison
Compare NOTE & MGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NOTE
- MGX
- Stock Information
- Founded
- NOTE 2013
- MGX 2018
- Country
- NOTE United States
- MGX United States
- Employees
- NOTE N/A
- MGX N/A
- Industry
- NOTE EDP Services
- MGX
- Sector
- NOTE Technology
- MGX
- Exchange
- NOTE Nasdaq
- MGX NYSE
- Market Cap
- NOTE 169.3M
- MGX 150.1M
- IPO Year
- NOTE N/A
- MGX 2024
- Fundamental
- Price
- NOTE $1.27
- MGX $2.61
- Analyst Decision
- NOTE Strong Buy
- MGX Strong Buy
- Analyst Count
- NOTE 6
- MGX 7
- Target Price
- NOTE $3.30
- MGX $16.67
- AVG Volume (30 Days)
- NOTE 4.0M
- MGX 1.0M
- Earning Date
- NOTE 03-11-2025
- MGX 02-12-2025
- Dividend Yield
- NOTE N/A
- MGX N/A
- EPS Growth
- NOTE N/A
- MGX N/A
- EPS
- NOTE N/A
- MGX N/A
- Revenue
- NOTE $125,062,000.00
- MGX $55,080,000.00
- Revenue This Year
- NOTE N/A
- MGX $16.91
- Revenue Next Year
- NOTE $4.01
- MGX N/A
- P/E Ratio
- NOTE N/A
- MGX N/A
- Revenue Growth
- NOTE N/A
- MGX 45.13
- 52 Week Low
- NOTE $0.75
- MGX $1.61
- 52 Week High
- NOTE $2.27
- MGX $12.74
- Technical
- Relative Strength Index (RSI)
- NOTE 55.08
- MGX 39.42
- Support Level
- NOTE $0.98
- MGX $2.67
- Resistance Level
- NOTE $1.37
- MGX $4.06
- Average True Range (ATR)
- NOTE 0.15
- MGX 0.31
- MACD
- NOTE -0.00
- MGX -0.16
- Stochastic Oscillator
- NOTE 53.70
- MGX 2.62
About NOTE FiscalNote Holdings Inc.
FiscalNote Holdings Inc is a provider of global policy and market intelligence solutions. Leveraging AI and analytics, it delivers actionable legal and policy insights for businesses, government institutions, and nonprofits. Its suite of products includes FiscalNote Core, CQ Federal, and EU Issue Tracker, facilitating effective policy management and risk mitigation. With expert analysis from FrontierView, Oxford Analytica, and Dragonfly Eye, it offers geopolitical and market intelligence services. Operating as one segment, it generates revenue by integrating policy intelligence into daily operations. Geographically the company generates the majority of its revenue from North America, Europe, Australia, and Asia, with the majority generated from North America.
About MGX METAGENOMI INC
Metagenomi Inc is a genetic medicines company committed to developing curative therapeutics for patients using its proprietary, comprehensive metagenomics-derived genome editing toolbox. Genetic diseases are caused by a diverse set of mutations that have been largely inaccessible by genome engineering approaches to date. The genome editing toolbox includes programmable nucleases, base editors, and RNA and DNA-mediated integration systems (including prime editing systems and clustered regularly interspaced short palindromic repeat (CRISPR)-associated transposases (CASTs).